General and late-breaking abstracts should present new research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. The CROI Scientific Program Committee and external reviewers review and score submissions. Abstracts are selected on the basis of their medical and scientific significance, timeliness, quality of data and methodology, and adherence to specific format requirements described below.
As always, the best and most consequential original research will define the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. Abstracts that have not been published or presented at a large HIV or SARS-CoV-2 conference prior to CROI will be eligible for inclusion at CROI, the world’s foremost conference of its kind.